COVID-19 Disease Clinical Manifestations and Treatment Result Analysis

From March 2nd, 2020th, this hospital started as a mainly for COVID-19 infections and has been continuously treating inpatients until now, January 5th, 2022th. the beginning of February, to 2022th, total cumulative number confirmed cases in Korea was 649,669, death toll 5,838, mortality rate 0.89%. The Korean quarantine system hospitalizes patients early stages (COVID-19) disease. We believe that it is due able keep considerably low compared many other countries. In paper, with data on 2,925 hospitalized from 2, 2020 September 30, 2021 at hospital, paper analyzes disease patterns patients, by analyzing clinical features medication history existing diseases who were hospital. important thing Regdanvimab (Regkirona) should administered possible stage infection Veklury (Remdesivir) also be soon time when oxygen saturation starts drop. It believed current Korea, which allows treated hospitals initial diagnosis, lowered COVID-19.